Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

IONOSENSE-POC

Financiado

Exploitation of Organic Electrochemical Transistors for Biological Ionsensing...

Exploitation of Organic Electrochemical Transistors for Biological Ionsensing Proof Of Concept The IONOSENSE-POC project proposes a novel solution to enable label-free, electronic monitoring of live cells in vitro, using innovative organic bioelectronic technology. The device, the organic electrochemical transistor (OECT),... ver más

30/09/2016

ARMINES

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2016-09-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-PoC-2014: ERC Proof of Concept Grant

I+D

Cerrada hace 10 años

0% 100%

3 Participantes

ARMINES

149.67K€ | Lider

SPORT ENEBE SL EN LIQUIDACIO...

INSTITUT MINESTELECOM

21.92K€ | Participante

Proyectos interesantes

CTQ2015-70023-R BIOMARCADORES DE ENVEJECIMIENTO: MONITORIZACION EN MUESTRAS... 117K€ Cerrado

PTQ-09-01-00682 Estudio de viabilidad de una plataforma de biomonitorización... 83K€ Cerrado

MAT2015-72760-EXP PLATAFORMA DE BIOSENSORES BASADOS EN TRANSISTORES ORGANICOS... 67K€ Cerrado

PDC2021-121511-I00 BIOSENSORES RAPIDOS Y DE BAJO COSTE PARA EL DIAGNOSTICO EN E... 109K€ Cerrado

RTC-2015-4380-1 Dispositivos Electrónicos Flexibles para control y supervisi... 198K€ Cerrado

FJC2020-043927-I Development of a sensitivity-advanced electrophoretic point-... 53K€ Cerrado

Últimas noticias

25-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 52 concesiones

25-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 1 concesiones

25-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 6 concesiones

Duración del proyecto: 18 meses Fecha Inicio: 2015-03-16
Fecha Fin: 2016-09-30

Presupuesto del proyecto 150K€

Descripción del proyecto The IONOSENSE-POC project proposes a novel solution to enable label-free, electronic monitoring of live cells in vitro, using innovative organic bioelectronic technology. The device, the organic electrochemical transistor (OECT), integrated with live cells forming a tissue, has been shown to accurately assess the integrity of the cells, providing dynamic, highly sensitive measurements after exposure to toxins/pathogens. Validation against traditional, optical methods, or commercially available electronic monitoring equipment demonstrated the OECT to have equal or improved sensitivity and temporal resolution. As an added bonus, the OECT is fabricated using conducting polymers, which are not only amenable to low cost processing techniques, but are also optically transparent, yielding devices compatible with high resolution imaging techniques, of critical importance to life scientists. In the POC project, we propose to take this extremely promising technological breakthrough developed in an academic environment, and transition it to a prototype suitable for future commercialization. In parallel, the appropriate steps will be taken necessary to ascertain the market niche(s), initially identified as being in the areas of Biomems targeted for diagnostics/drug discovery. Finally, an adapted exploitation strategy will be developed to best suit the technology developed during the IONOSENSE project. The team assembled to execute the project is extremely committed to the commercialization venture, in particular due to significant feedback from industrial partners (potential endusers) from such diverse biomedical applications as the cosmetics industry, neurotoxicology, electrophysiology instrumentation developers, drug development companies etc. The success of this POC project will have broad ranging, highly positive impacts for society in the EU and further, due to reduction of experimentation on animals, improved healthcare outcomes, and economic development to name a few.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores